Literature DB >> 8101966

Amino acid substitutions at position 312 in the seventh hydrophobic segment of the beta 2-adrenergic receptor modify ligand-binding specificity.

S Suryanarayana1, B K Kobilka.   

Abstract

We previously reported that Asn312 of the beta 2-adrenergic receptor and Asn385 in the homologous position in the 5-hydroxytryptamine1A receptor are important for binding to a class of beta-adrenergic receptor antagonists including propranolol and alprenolol. We proposed that the asparagine may be forming a hydrogen bond with the phenoxy oxygen common to these ligands. To further test this hypothesis we made alanine, threonine, phenylalanine, and glutamine substitutions at position 312 in the beta 2-adrenergic receptor. We observed that substitution with amino acids that permit formation of hydrogen bonds (threonine and glutamine) supported binding to aryloxyalkylamines, whereas substitution with amino acids that cannot form hydrogen bonds (alanine and phenylalanine) did not permit binding to these compounds. We were surprised to find that two of these substitutions led to an increase in affinity for alpha-adrenergic ligands. Substitution with glutamine and threonine at position 312 led to a 11-15-fold increase in affinity for yohimbine and enabled p-aminoclonidine to act as an agonist. These results further emphasize the role of position 312 in the formation of the ligand binding site for multiple ligands.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8101966

Source DB:  PubMed          Journal:  Mol Pharmacol        ISSN: 0026-895X            Impact factor:   4.436


  15 in total

1.  Structural requirements of bitter taste receptor activation.

Authors:  Anne Brockhoff; Maik Behrens; Masha Y Niv; Wolfgang Meyerhof
Journal:  Proc Natl Acad Sci U S A       Date:  2010-06-01       Impact factor: 11.205

2.  A structural chemogenomics analysis of aminergic GPCRs: lessons for histamine receptor ligand design.

Authors:  A J Kooistra; S Kuhne; I J P de Esch; R Leurs; C de Graaf
Journal:  Br J Pharmacol       Date:  2013-09       Impact factor: 8.739

3.  The structural basis of G-protein-coupled receptor signaling (Nobel Lecture).

Authors:  Brian Kobilka
Journal:  Angew Chem Int Ed Engl       Date:  2013-05-06       Impact factor: 15.336

4.  Molecular Architecture of G Protein-Coupled Receptors.

Authors:  A Michiel van Rhee; Kenneth A Jacobson
Journal:  Drug Dev Res       Date:  1996-01-01       Impact factor: 4.360

5.  β2-Adrenergic Receptor Conformational Response to Fusion Protein in the Third Intracellular Loop.

Authors:  Matthew T Eddy; Tatiana Didenko; Raymond C Stevens; Kurt Wüthrich
Journal:  Structure       Date:  2016-11-10       Impact factor: 5.006

6.  Analysis of L-DOPA and droxidopa binding to human β2-adrenergic receptor.

Authors:  Akash Deep Biswas; Andrea Catte; Giordano Mancini; Vincenzo Barone
Journal:  Biophys J       Date:  2021-11-10       Impact factor: 4.033

7.  Analysis of full and partial agonists binding to beta2-adrenergic receptor suggests a role of transmembrane helix V in agonist-specific conformational changes.

Authors:  Vsevolod Katritch; Kimberly A Reynolds; Vadim Cherezov; Michael A Hanson; Christopher B Roth; Mark Yeager; Ruben Abagyan
Journal:  J Mol Recognit       Date:  2009 Jul-Aug       Impact factor: 2.137

8.  Identification of an adenosine receptor domain specifically involved in binding of 5'-substituted adenosine agonists.

Authors:  M E Olah; K A Jacobson; G L Stiles
Journal:  J Biol Chem       Date:  1994-07-08       Impact factor: 5.157

9.  Potential modes of interaction of 9-aminomethyl-9,10-dihydroanthracene (AMDA) derivatives with the 5-HT2A receptor: a ligand structure-affinity relationship, receptor mutagenesis and receptor modeling investigation.

Authors:  Scott P Runyon; Philip D Mosier; Bryan L Roth; Richard A Glennon; Richard B Westkaemper
Journal:  J Med Chem       Date:  2008-10-11       Impact factor: 7.446

10.  Ring substituents on substituted benzamide ligands indirectly mediate interactions with position 7.39 of transmembrane helix 7 of the D4 dopamine receptor.

Authors:  Spencer S Ericksen; David F Cummings; Michael E Teer; Shahnawaz Amdani; John A Schetz
Journal:  J Pharmacol Exp Ther       Date:  2012-05-15       Impact factor: 4.030

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.